Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209

Annals of Oncology

Volumn 25, Issue 6, 2014, Pages 1192-1198

  Kitamura, Hiroshi ^a   Tsukamoto, T ^a   Shibata, T ^b   Masumori, N ^a   Fujimoto, H ^c   Hirao, Y ^d   Fujimoto, K ^d   Kitamura, Y ^e   Tomita, Y ^f   Tobisu, K ^g   Niwakawa, M ^g   Naito, S ^h   Eto, M ⁱ   Kakehi, Y ^j  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NATIONAL CANCER CENTER   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

^d NARA MEDICAL UNIVERSITY   (Japan)

^e NIIGATA CANCER CENTER HOSPITAL   (Japan)

^f YAMAGATA UNIVERSITY   (Japan)

^g SHIZUOKA CANCER CENTER   (Japan)

^h KYUSHU UNIVERSITY   (Japan)

ⁱ KUMAMOTO UNIVERSITY   (Japan)

^j KAGAWA UNIVERSITY   (Japan)

more..

Author keywords

Bladder cancer; Neoadjuvant chemotherapy; Radical cystectomy

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; VINBLASTINE; ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGED; ANASTOMOSIS LEAKAGE; ANASTOMOTIC STRICTURE; ARTERY INJURY; ARTICLE; CANCER ADJUVANT THERAPY; CONTROLLED STUDY; CYSTECTOMY; DRUG FATALITY; DRUG SAFETY; FEMALE; HUMAN; HYPOTENSION; ILEUS; LYMPH LEAKAGE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MUSCLE INVASIVE BLADDER CANCER; NEUROPATHY; NEUTROPENIA; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VEIN INJURY; WOUND INFECTION; CARCINOMA, TRANSITIONAL CELL; CLINICAL TRIAL; DISEASE FREE SURVIVAL; JAPAN; KAPLAN MEIER METHOD; MIDDLE AGED; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PROPORTIONAL HAZARDS MODEL; URINARY BLADDER NEOPLASMS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; CISPLATIN; COMBINED MODALITY THERAPY; CYSTECTOMY; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; JAPAN; KAPLAN-MEIER ESTIMATE; MALE; METHOTREXATE; MIDDLE AGED; NEOADJUVANT THERAPY; PROPORTIONAL HAZARDS MODELS; QUALITY OF LIFE; URINARY BLADDER NEOPLASMS; VINBLASTINE;

EID: 84903878535     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu126     Document Type: Article

References (18)

1. Hautmann RE, de Petriconi RC, Pfeiffer C et al. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol 2012; 61: 1039-1047.
2. Takahashi A, Tsukamoto T, Tobisu K et al. Radical cystectomy for invasive bladder cancer: results of multi-institutional pooled analysis. Jpn J Clin Oncol 2004; 34: 14-19.
3. Nishiyama H, Habuchi T, Watanabe J et al. Clinical outcome of a large-scale multiinstitutional retrospective study for locally advanced bladder cancer: a survey including 1131 patients treated during 1990-2000 in Japan. Eur Urol 2004; 45: 176-181.
4. Grossman HB, Natale RB, Tangen CM et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 2003; 349: 859-866.
5. International Collaboration of Trialists, Medical Research Council Advanced Bladder Cancer Working Party, European Organisation for Research and Treatment of Cancer Genito-Urinary Tract Cancer Group et al. International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. J Clin Oncol 2011; 29: 2171-2177.
6. Malmstrom PU, Rintala E, Wahlqvist R et al. Five-year followup of a prospective trial of radical cystectomy and neoadjuvant chemotherapy: Nordic Cystectomy Trial I. The Nordic Cooperative Bladder Cancer Study Group. J Urol 1996; 155: 1903-1906.
7. Sherif A, Rintala E, Mestad O et al. Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer-Nordic Cystectomy Trial 2. Scand J Urol Nephrol 2002; 36: 419-425.
8. Advanced Bladder Cancer Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005; 48: 202-205.
9. Winquist E, Kirchner TS, Segal R et al. Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis. J Urol 2004; 171: 561-569.
10. David KA, Milowsky MI, Ritchey J et al. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. J Urol 2007; 178: 451-454.
11. Burger M, Mulders P, Witjes W. Use of neoadjuvant chemotherapy for muscleinvasive bladder cancer is low among major European centres: results of a feasibility questionnaire. Eur Urol 2012; 61: 1070-1071.
12. JCOG Surgical Committee. JCOG surgical morbidity criteria. 2005 (Japanese). http://www.jcog.jp/doctor/tool/C_150_0021.pdf (27 September 2013, date last accessed).
13. Herr HW, Bochner BH, Dalbagni G et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002; 167: 1295-1298.
14. Tilki D, Svatek RS, Novara G et al. Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients. J Urol 2010; 184: 888-894.
15. May M, Bastian PJ, Burger M et al. Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder. BJU Int 2011; 108: E278-E283.
16. Johnson DC, Nielsen ME, Matthews J et al. Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity. BJU Int 2013 November 26 [epub ahead of print], doi: 10.1111/bju.12585.
17. Igawa M, Kadena H, Ohkuchi T et al. [Methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) in advanced urothelial cancer-analysis of efficacy and toxicity]. Nihon Hinyokika Gakkai Zasshi 1991; 82: 1627-1636.
18. Millikan R, Dinney C, Swanson D et al. Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol 2001; 19: 4005-4013.